Peripheral Blood Dendritic Cells Are Not a Major Reservoir for HIV Type 1 in Infected Individuals on Virally Suppressive HAART

AIDS Research and Human Retroviruses

Volumn 19, Issue 12, 2003, Pages 1097-1103

  Otero, Miguel ^a   Nunnari, Giuseppe ^a   Leto, Daniela ^a   Sullivan, Julie ^a   Wang, Feng Xiang ^a   Frank, Ian ^b   Xu, Yan ^a   Patel, Charvi ^a   Dornadula, Geethanjali ^a   Kulkosky, Joseph ^a,c   Pomerantz, Roger J ^a,d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHESTNUT HILL COLLEGE   (United States)

^d Center for Human Virology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; DIDANOSINE; EFAVIRENZ; GAG PROTEIN; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NELFINAVIR; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ARTICLE; BLOOD; BONE MARROW; CLINICAL ARTICLE; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; GROUP SPECIFIC ANTIGEN GENE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DEPLETION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; VIRION; VIROGENESIS; VIRUS GENE; VIRUS INHIBITION; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DENDRITIC CELLS; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR;

EID: 9144220238     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203771881194     Document Type: Article

References (32)

1. Patella FJ, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
2. Hammer SM, Squires KE, Hughes MD, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-733.
3. Gupta P, Mellors J, Kingsley L, et al.: High viral load in semen of human immunodeficiency virus type I-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol 1997;71:6271-6275.
4. Chun TW, Carruth L, Finzi D, et al.: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997;387:183-188.
5. Dornadula G, Zhang H, VanUitert B, et al.: Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA 1999;282:1627-1632.
6. Finzi D, Hermankova M, Pierson T, et al.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278:1295-1300.
7. Zhang H, Dornadula G, Beumont M, et al.: Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998;339:1803-1809.
8. Pomerantz RJ: Residual HIV-1 infection during antiretroviral therapy: The challenge of viral persistence. AIDS 2001;15:1201-1211.
9. Sonza S, Mutimer HP, Oelrichs R, et al.: Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 2001;15:17-22.
10. Valentin A, Rosati M, Patenaude DJ, Hatzakis A, Kostrikis LG, Lazanas M, Wyvill KM, Yarchoan R, and Pavlakis GN: Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy. Proc Natl Acad Sci USA 2002;99: 7015-7020.
11. Saha K, Zhang J, Gupta A, Dave R, Yimen M, and Zerhouni B: Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor. Nat Med 2001;7:65-72.
12. Simmons G, Reeves JD, Hibbitts S, Stine JT, Gray PW, Proudfoot AE, and Clapham PR: Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol Rev 2000; 177:112-126.
13. Rowland-Jones SL: HIV: The deadly passenger in dendritic cells. Curr Biol 1999;9:R248-R250.
14. Cameron PU, Freudenthal PS, Barker JM, et al.: Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous infection to CD4+ T cells. Science 1992;257:383-387.
15. Weissman D, Ananworanich J, Zhou L-J, et al.: Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1995;92:826-830.
16. Gummuluru S, KewalRamani VN, and Emerman M: Dendritic cell-mediated viral transfer to T cells is required for human immunodeficiency virus type 1 persistence in the face of rapid cell turnover. J Virol 2002;76:10692-10701.
17. Langhoff E, Terwilliger EF, Bos HJ, Kalland KH, Poznansky MC, Bacon OM, and Haseltine WA: Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc Natl Acad Sci USA 1991;88:7998-8002.
18. Patterson S, Roberts MS, English NR, et al.: Detection of HIV DNA in peripheral blood dendritic cells of HIV-1 infected individuals. Res Virol 1994;145:171-176.
19. Macatonia SE, Lau R, Patterson S, et al.: Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 1990;71:38-45.
20. Hughes RA, Macatonia SE, Rowe IF, et al.: The detection of human immunodeficiency virus DNA in dendritic cells from the joints of patients with aseptic arthritis. Br J Rheumatol 1990;29: 166-170.
21. Dornadula G, Nunnari G, Vanella M et al.: Human immunodeficiency virus type 1 infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologie and immunologic subgroups. J Infect Dis 2001;183:1682-1687.
22. Zhang H, Bagasra O. Niikura M, Poiesz BJ, and Pomerantz RJ: Intravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals. J Virol 1994;68:7591-7597.
23. Geijtenbeek TB, Kwon DS, Torensma R, et al.: DC-SIGN, a dendritic cell-specific HIV-1 binding protein that enhances trans-infection of T cells. Cell 2000;100:587-597.
24. Kwon DS, Gregorio G, Bitton N, Hendrickson WA, and Littman DR: DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 2002;16:135-144.
25. Moir S, Malaspina A, Li Y, et al.: B cells of HIV-1 infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J Exp Med 2000;195:637-646.
26. Pope M, Betjes MGH, Romani N, Hirmand H, Cameron PU, Hoffman L, Gezelter G, Shuler G, and Steinman RM: Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994;78:389-398.
27. Henry MA, Uthman C, Ballaun C, Stingl G, and Tschachler E: Epidermal langerhans cells of AIDS patients express HIV-1 regulatory and structural genes. J Invest Dermatol 1994;103:593-596.
28. Smith BA, Gartner S, Liu Y, Perelson AS, Stilianakis NI, Keele BF, Kerkering TM, Ferreira-Gonzalez A, Szakal AK, Tew JG, and Burton GF: Persistence of infectious HIV on follicular dendritic cells. J Immunol 2001;166:690-696.
29. Cavert W, Notermans DW, Staskus K, et al.: Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997;276:960-964.
30. Hlavacek WS, Wofsy C, and Perelson AS: Dissociation of HIV-1 from follicular dendritic cells during HAART: Mathematical analysis. Proc Natl Acad Sci USA 1999;96:14681-14686.
31. Hlavacek WS, Stilianakis NI, Notermans SA, et al.: Influence of follicular dendritic cells on decay if HIV during antiretroviral therapy. Proc Natl Acad Sci USA 2000;97:10966-10971.
32. Donaghy H, Gazzard B, Gotch F, and Patterson S: Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 2003;101:4505-4511.